Lowering cholesterol with medicine | Dr Thomas Dayspring and Dr Dan Soffer

In this episode, I’m joined by Dr Tom Dayspring and Dr Dan Soffer for a comprehensive look at lipid-lowering therapy. We unpack the science behind statins, ezetimibe, PCSK9 inhibitors, fibrates, and newer agents like bempedoic acid, asking what really works, who should take them, and how early treatment might prevent disease. From guideline thresholds to real-world decision making, historical trials to future therapies, this conversation offers clarity on one of the most important areas in cardiovascular prevention. In this episode, we cover: What lipid-lowering therapy actually is Statins, ezetimibe, fibrates, and PCSK9 inhibitors How these drugs work and who benefits most Absolute vs relative risk reduction explained Guidelines vs clinical practice Lipoprotein(a) and new therapies on the horizon A detailed yet practical discussion to help you cut through the noise and make sense of lipid-lowering therapies. Intro: What Are Cholesterol-Lowering Drugs and How...